Sana Biotechnology, Inc. (SANA) Tops Q3 EPS by 4c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q3 EPS of ($0.41), $0.04 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Worthington Enterprises raises dividend 5%, adds board member
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance